HCPCS Level II drug code
J7502 — Cyclosporine, oral, 100 mg
In short
J7502 is the HCPCS Level II code for cyclosporine, oral, 100 mg. CMS assigns NDCs for Cyclosporine, Gengraf, Neoral and Sandimmune to it. One billing unit is 100 mg. The Medicare Part B payment limit is $1.455 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Cyclosporine, oral, 100 mg
- Short descriptor
- Cyclosporine oral 100 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2000
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 100 mg. For example, 10000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J7502
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 14 NDCs to J7502 for Cyclosporine, Gengraf, Neoral and Sandimmune. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Cyclosporine | 00093-9018-65 | Teva Pharmaceuticals USA, Inc. | 30 | 8 |
| Cyclosporine | 00093-9019-65 | Teva Pharmaceuticals USA, Inc. | 30 | 15 |
| Cyclosporine | 00093-9020-65 | Teva Pharmaceuticals USA, Inc. | 30 | 30 |
| Cyclosporine | 00172-7313-20 | Ivax Pharmaceuticals, Inc. | 50 | 50 |
| Cyclosporine | 23155-0839-30 | Heritage Pharmaceuticals Inc. | 30 | 30 |
| Cyclosporine | 60505-0134-00 | Apotex Corp | 30 | 30 |
| Cyclosporine | 60505-4632-03 | Apotex Corp | 30 | 30 |
| Cyclosporine | 68084-0921-25 | American Health Packaging | 30 | 30 |
| Gengraf | 00074-3109-32 | AbbVie Inc. | 30 | 30 |
| Gengraf | 00074-7269-50 | AbbVie Inc. | 50 | 50 |
| Neoral | 00078-0248-15 | Novartis Pharmaceuticals Corporation | 30 | 30 |
| Neoral | 00078-0274-22 | Novartis Pharmaceuticals Corporation | 50 | 50 |
| Sandimmune | 00078-0110-22 | Novartis Pharmaceuticals Corporation | 50 | 50 |
| Sandimmune | 00078-0241-15 | Novartis Pharmaceuticals Corporation | 30 | 30 |
J7502: common questions
- Is J7502 a CPT code?
- No. J7502 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J7502?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 14 NDCs under J7502, for Cyclosporine, Gengraf, Neoral and Sandimmune. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J7502?
- $1.455 per 100 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J7502?
- One unit of J7502 is 100 mg, as stated in the code's descriptor. Units to report = dose given ÷ 100 mg. J-code billing units.